Published in J Neurochem on January 01, 1993
Insular and caudate lesions release abnormal yawning in stroke patients. Brain Struct Funct (2013) 0.80
Alterations in serotonin receptors and transporter immunoreactivities in the hippocampus in the rat unilateral hypoxic-induced epilepsy model. Cell Mol Neurobiol (2011) 0.79
Ischemia-induced cell depolarization: does the hyperpolarization-activated cation channel HCN2 affect the outcome after stroke in mice? Exp Transl Stroke Med (2013) 0.75
Cerebral blood flow in dementia. Arch Neurol (1975) 9.24
Thresholds in cerebral ischemia - the ischemic penumbra. Stroke (1982) 5.20
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke (1977) 2.51
Smoking and subarachnoid haemorrhage. Br Med J (1979) 2.02
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Pressure waves in so-called low-pressure hydrocephalus. Lancet (1972) 1.94
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery. J Neurosurg (1975) 1.89
Regional blood flow in the normal cerebral hemisphere. J Neurol Neurosurg Psychiatry (1969) 1.84
Effect of haematocrit on cerebral blood-flow in man. Lancet (1977) 1.80
Cerebral blood-flow in polycythaemia. Lancet (1977) 1.79
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
Mechanisms and treatment in post-traumatic syringomyelia. Br J Neurosurg (1989) 1.64
Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke (1986) 1.58
Meningiomas of the clivus and apical petrous bone. Report of 35 cases. J Neurosurg (1986) 1.49
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
Cavernous angioma of the cerebello-pontine angle: a case report. Br J Neurosurg (1991) 1.41
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry (1979) 1.33
Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol (1974) 1.31
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Clinical features, investigation and treatment of post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry (1981) 1.29
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
Changes in extracellular calcium activity in cerebral ischaemia. J Cereb Blood Flow Metab (1981) 1.26
Dural arteriovenous malformations of the spine. Clinical features and surgical results in 55 cases. J Neurosurg (1984) 1.24
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
An intravenous 133xenon clearance technique for measuring cerebral blood flow. J Neurol Sci (1979) 1.22
Extracellular potassium activity, evoked potential and tissue blood flow. Relationships during progressive ischaemia in baboon cerebral cortex. J Neurol Sci (1977) 1.18
Intraventricular meningioma. A review of 10 cases of the National Hospital, Queen Square (1974-1985) with reference to the literature. Acta Neurochir (Wien) (1986) 1.18
Computed tomography in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1980) 1.17
The anaesthetist's effect upon the cerebral arteries. Proc R Soc Med (1971) 1.15
Central conduction time as an index of ischaemia in subarachnoid haemorrhage. J Neurol Sci (1979) 1.14
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
Epidermoid cysts and cholesterol granulomas centered on the posterior fossa: twenty years of diagnosis and management. Neurosurgery (1987) 1.14
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
The hydrogen clearance method in assessment of blood flow in cortex, white matter and deep nuclei of baboons. Stroke (1973) 1.10
Surgical management of suprasellar meningioma. Part 1: The influence of tumor size, duration of symptoms, and microsurgery on surgical outcome in 101 consecutive cases. J Neurosurg (1984) 1.10
Studies of leptomeningeal collateral circulation in Macacus rhesus. J Physiol (1961) 1.08
Syringoperitoneal shunt for treatment of cord cavitation. J Neurol Neurosurg Psychiatry (1985) 1.06
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Haemorrhage in pituitary tumours. Acta Neurochir (Wien) (1982) 1.05
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
The surgical treatment of cervical spondylotic myelopathy. Neurology (1967) 1.04
Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry (1979) 1.04
Cerebral blood flow and edema following carotid occlusion in the gerbil. Stroke (1980) 1.04
Local cerebral blood flow and vascular reactivity in a chronic stable stroke in baboons. Stroke (1975) 1.04
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Difficulties in diagnosis of supratentorial gliomas by CAT scan. J Neurol Neurosurg Psychiatry (1979) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Variations in mean cerebral blood flow under anesthesia at rest and during cortical activation. Stroke (1977) 1.03
The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke (1983) 1.03
Observations on the leptomeningeal collateral circulation in dogs. J Physiol (1960) 1.03
An experimental study of traumatic cerebral vascular spasm. J Neurol Neurosurg Psychiatry (1967) 1.02
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Arteriovenous malformations of the spinal cord. Adv Tech Stand Neurosurg (1984) 1.00
Biochemical indices of brain structure, function and "hypoxia" in cortex from baboons with middle cerebral artery occlusion. Brain Res (1976) 1.00
Jugular foramen neuromas: a review of 14 cases. Surg Neurol (1990) 1.00
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
Colloid cysts of the third ventricle. A review of 36 cases. Acta Neurochir (Wien) (1985) 1.00
A study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke (1973) 0.99
Glomus jugulare tumours: a review of 61 cases. Acta Neurochir (Wien) (1994) 0.99
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
Autoregulation in acute focal ischemia. An experimental study. Stroke (1977) 0.99
Disordered cerebro-vascular physiology in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) (1978) 0.99
Effect of high haematocrit on alertness. Lancet (1980) 0.99
Angiographically occult arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry (1978) 0.98
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Noninvasive intraoperative monitoring of motor evoked potentials under propofol anesthesia: effects of spinal surgery on the amplitude and latency of motor evoked potentials. Neurosurgery (1991) 0.97
Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem (1995) 0.96
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Ischemic brain edema following middle cerebral artery occlusion in baboons: relationship between regional cerebral water content and blood flow at 1 to 2 hours. Stroke (1979) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Intracranial neurenteric cysts. Report of two cases. J Neurosurg (1991) 0.95
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
Cerebral arterial reactivity and spasm after subarachnoid haemorrhage. Proc R Soc Med (1972) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
Surgical management of spinal cord cavernoma. Br J Neurosurg (1995) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Supratentorial intraventricular hemangioblastoma: case report and review of literature. Surg Neurol (1981) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95